Evaluation of Benztropine for Cocaine Craving - 2

Phase 2

Completed

• Conditions: Cocaine-Related Disorders

• Registration Number: NCT00000333
• Lead Sponsor: National Institute on Drug Abuse (NIDA)

Brief Summary

The purpose of this study is to compare the efficacy of benztropine (or DA reuptake inhibitor) with atropine and placebo in affecting stimulated craving to cocaine cues.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 1999-09-20
• Study First Submitted QC: 1999-09-20
• Study First Posted: 1999-09-21
• Study Start: 2001-05
• Status Verified: 2002-12
• Primary Completion: 2003-01
• Study Completion: 2003-04
• Last Update Submitted: 2017-02-23
• Last Update Posted: 2017-02-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Stimulated and non-stimulated craving

Trial Locations

Locations (1)

Washington DC VA; 🇺🇸 Washington, District of Columbia, United States